Olumiant 2 mg film-coated tablets, Olumiant 4 mg film-coated tablets
APHP220916
Phase 2 small_molecule active
Quick answer
Olumiant 2 mg film-coated tablets, Olumiant 4 mg film-coated tablets for -women with an inflammatory HCA proven at histology and with at least one inflammatory HCA of more than 5 cm. -male with at least one inflammatory HCA proven at histology whatever the size and considered as non resectable by the multidisciplinary tumor board is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- -women with an inflammatory HCA proven at histology and with at least one inflammatory HCA of more than 5 cm. -male with at least one inflammatory HCA proven at histology whatever the size and considered as non resectable by the multidisciplinary tumor board
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active